STOCK TITAN

IMV (IMV) Stock Price, News & Analysis

IMV NASDAQ

Company Description

IMV (NASDAQ: IMV) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $9.8M.

This page collects what Stock Titan holds for IMV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year

Latest News

IMV has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, conferences, clinical trial. View all IMV news →

SEC Filings

No SEC filings available for IMV.

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMV Company Profile & Sector Positioning

IMV (IMV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing IMV often look at related companies in the same sector, including In8Bio, Inc. (INAB), Diffusion Pharmaceuticals Inc. (DFFN), Bolt Biotherapeutics, Inc. (BOLT), Matinas Biopharm (MTNB), and Transcode Therapeutics Inc (RNAZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IMV's relative position within its industry.

Frequently Asked Questions

What is the market cap of IMV (IMV)?

The market cap of IMV (IMV) is approximately 9.8M. Learn more about what market capitalization means .